EMCURE
Invest with MTF
Invest Now
Invest in Emcure Pharmaceuticals with 3.28X leverage
Performance
- Low
- ₹1,388
- High
- ₹1,445
- 52 Week Low
- ₹889
- 52 Week High
- ₹1,520
- Open Price₹1,401
- Previous Close₹1,402
- Volume311,922
Investment Returns
- Over 1 Month + 2.82%
- Over 3 Month + 9.71%
- Over 6 Month + 12.62%
- Over 1 Year -3.2%
Smart Investing Starts Here Start SIP with Emcure Pharmaceuticals for Steady Growth!
Emcure Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 34.2
- PEG Ratio
- 0.9
- Market Cap Cr
- 27,126
- P/B Ratio
- 5.7
- Average True Range
- 45.33
- EPS
- 42.32
- Dividend Yield
- 0.2
- MACD Signal
- 4.89
- RSI
- 56.2
- MFI
- 60.59
Emcure Pharmaceuticals Financials
Emcure Pharmaceuticals Technicals
EMA & SMA
Current Price
₹1,430.90
+
29.1
(2.08%)
- Bearish Moving Average 0
- Bullish Moving Average 16
- 20 Day
- ₹1,400.19
- 50 Day
- ₹1,389.30
- 100 Day
- ₹1,369.71
- 200 Day
- ₹1,348.93
Resistance and Support
1421.43
- R3 1,511.97
- R2 1,478.63
- R1 1,454.77
- S1 1,397.57
- S2 1,364.23
- S3 1,340.37
Emcure Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends
Emcure Pharmaceuticals F&O
About Emcure Pharmaceuticals
- NSE Symbol
- EMCURE
- BSE Symbol
- 544210
- Managing Director & CEO
- Mr. Satish Ramanlal Mehta
- ISIN
- INE168P01015
Similar Stocks to Emcure Pharmaceuticals
Emcure Pharmaceuticals FAQs
Emcure Pharmaceuticals share price is ₹1,430 As on 03 January, 2026 | 14:39
The Market Cap of Emcure Pharmaceuticals is ₹27125.9 Cr As on 03 January, 2026 | 14:39
The P/E ratio of Emcure Pharmaceuticals is 34.2 As on 03 January, 2026 | 14:39
The PB ratio of Emcure Pharmaceuticals is 5.7 As on 03 January, 2026 | 14:39
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.